6. Infection Risks in CHS: Understanding and Managing the Threat
Individuals with CHS face a significantly increased risk of infections. This susceptibility stems from the impaired function of their immune cells, which are essential in fighting off pathogens. Recognizing and managing these risks is a critical aspect of CHS care.
Patients with CHS are particularly prone to bacterial, viral, and fungal infections. These can range from mild to life-threatening, depending on the severity of the immune deficiency. Respiratory and skin infections are among the most common, requiring vigilant monitoring and prompt treatment.
Preventive measures are key to managing infection risks. This includes maintaining good hygiene, avoiding exposure to known pathogens, and adhering to vaccination schedules. Prophylactic antibiotics may also be prescribed to reduce the risk of recurrent infections.
Effective management of infection risks in CHS requires a collaborative approach with healthcare providers. Regular medical check-ups, tailored treatment plans, and education about recognizing early signs of infection are essential components of comprehensive care. (6)
